307 related articles for article (PubMed ID: 24658154)
1. Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.
Nair SK; De Leon G; Boczkowski D; Schmittling R; Xie W; Staats J; Liu R; Johnson LA; Weinhold K; Archer GE; Sampson JH; Mitchell DA
Clin Cancer Res; 2014 May; 20(10):2684-94. PubMed ID: 24658154
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cells cross-talk with tumour antigen-specific CD8
Eiraku Y; Terunuma H; Yagi M; Deng X; Nicol AJ; Nieda M
Clin Exp Immunol; 2018 Oct; 194(1):54-66. PubMed ID: 30009488
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
[TBL] [Abstract][Full Text] [Related]
4. Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.
Reap EA; Suryadevara CM; Batich KA; Sanchez-Perez L; Archer GE; Schmittling RJ; Norberg PK; Herndon JE; Healy P; Congdon KL; Gedeon PC; Campbell OC; Swartz AM; Riccione KA; Yi JS; Hossain-Ibrahim MK; Saraswathula A; Nair SK; Dunn-Pirio AM; Broome TM; Weinhold KJ; Desjardins A; Vlahovic G; McLendon RE; Friedman AH; Friedman HS; Bigner DD; Fecci PE; Mitchell DA; Sampson JH
Cancer Res; 2018 Jan; 78(1):256-264. PubMed ID: 29093005
[TBL] [Abstract][Full Text] [Related]
5. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P
Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490
[TBL] [Abstract][Full Text] [Related]
6. The detection of CMV pp65 and IE1 in glioblastoma multiforme.
Lucas KG; Bao L; Bruggeman R; Dunham K; Specht C
J Neurooncol; 2011 Jun; 103(2):231-8. PubMed ID: 20820869
[TBL] [Abstract][Full Text] [Related]
7. Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells.
Forsberg O; Carlsson B; Tötterman TH; Essand M
Br J Haematol; 2008 Apr; 141(2):188-99. PubMed ID: 18307565
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous generation of cytomegalovirus-specific CD8+ and CD4+ T lymphocytes by use of dendritic cells comodified with pp65 mRNA and pp65 protein.
Carlsson B; Hou M; Giandomenico V; Nilsson B; Totterman TH; Essand M
J Infect Dis; 2005 Dec; 192(11):1912-20. PubMed ID: 16267762
[TBL] [Abstract][Full Text] [Related]
9. Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus.
Akiyama Y; Maruyama K; Mochizuki T; Sasaki K; Takaue Y; Yamaguchi K
Immunol Lett; 2002 Aug; 83(1):21-30. PubMed ID: 12057851
[TBL] [Abstract][Full Text] [Related]
10. Improved Function and Maturation of Dendritic Cells Stimulated by Recombinant pp65 Protein: An in-vitro Design.
Nikmanesh Y; Karimi MH; Yaghobi R; Marashi SM; Mahmoudi M; Moravej A; Shahmahmoodi S
Iran J Immunol; 2019 Mar; 16(1):11-25. PubMed ID: 30864552
[TBL] [Abstract][Full Text] [Related]
11. Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation.
Hanley PJ; Shaffer DR; Cruz CR; Ku S; Tzou B; Liu H; Demmler-Harrison G; Heslop HE; Rooney CM; Gottschalk S; Bollard CM
Cytotherapy; 2011 Sep; 13(8):976-86. PubMed ID: 21539497
[TBL] [Abstract][Full Text] [Related]
12. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
Tabi Z; Moutaftsi M; Borysiewicz LK
J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
[TBL] [Abstract][Full Text] [Related]
13. [CMV pp65 gene modified dendritic cells activate autologous T cells].
Gao GX; Chen XQ; Zhang JY; Zhu HF; Dong BX; Gu HT; Gao Y; Pan YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):397-400. PubMed ID: 18426673
[TBL] [Abstract][Full Text] [Related]
14. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.
Berencsi K; Gyulai Z; Gönczöl E; Pincus S; Cox WI; Michelson S; Kari L; Meric C; Cadoz M; Zahradnik J; Starr S; Plotkin S
J Infect Dis; 2001 Apr; 183(8):1171-9. PubMed ID: 11262198
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cytomegalovirus pp65-HLA-A24 peptide-specific CTL lines from metastatic melanoma patients.
Akiyama Y; Tai S; Komiyama M; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y
Oncol Rep; 2009 Jul; 22(1):185-91. PubMed ID: 19513522
[TBL] [Abstract][Full Text] [Related]
16. CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.
Knight A; Arnouk H; Britt W; Gillespie GY; Cloud GA; Harkins L; Su Y; Lowdell MW; Lamb LS
PLoS One; 2013; 8(8):e68729. PubMed ID: 23950874
[TBL] [Abstract][Full Text] [Related]
17. The matrix protein pp65(341-350): a peptide that induces ex vivo stimulation and in vitro expansion of CMV-specific CD8+ T cells in subjects bearing either HLA-A*2402 or A*0101 allele.
Provenzano M; Lim JB; Mocellin S; Monsurro V; Bettinotti M; Marincola FM; Stroncek DF
Transfusion; 2003 Nov; 43(11):1567-74. PubMed ID: 14617317
[TBL] [Abstract][Full Text] [Related]
18. Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.
Wakefield A; Pignata A; Ghazi A; Ashoori A; Hegde M; Landi D; Gray T; Scheurer ME; Chintagumpala M; Adesina A; Gottschalk S; Hicks J; Powell SZ; Ahmed N
J Neurooncol; 2015 Nov; 125(2):307-15. PubMed ID: 26341370
[TBL] [Abstract][Full Text] [Related]
19. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes.
McLaughlin-Taylor E; Pande H; Forman SJ; Tanamachi B; Li CR; Zaia JA; Greenberg PD; Riddell SR
J Med Virol; 1994 May; 43(1):103-10. PubMed ID: 8083644
[TBL] [Abstract][Full Text] [Related]
20. Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.
Ghazi A; Ashoori A; Hanley PJ; Brawley VS; Shaffer DR; Kew Y; Powell SZ; Grossman R; Grada Z; Scheurer ME; Hegde M; Leen AM; Bollard CM; Rooney CM; Heslop HE; Gottschalk S; Ahmed N
J Immunother; 2012; 35(2):159-68. PubMed ID: 22306904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
